Wednesday, April 25, 2007
Maraviroc, Pfizer's new drug for HIV has the backing of the FDA. It will be the first new drug against HIV in over a decade. It works by antagonizing the CCR5 receptor, and blocking virus entry. This is good news, and another success of targeted small mollecule therapy, and it was developed in a record 10 years!